Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 2 weeks TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical compa…
Author of the article:
Article content
Auditor Licensing & Personnel Issues Delays Issuance of Audit OpinionThe Company expects to file within 2 weeks
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) …